This week's FierceBiotech is brought to you by Premier Research.

Trouble viewing? Click here.




Identifying and Overcoming the Obstacles of Gene Therapy Trials



The next generation of gene therapy treatments holds enormous promise for treating a wide range of diseases like cancer, diabetes, and rare genetic disorders. Our white paper looks at what it takes to achieve operational excellence in gene therapy trials — overcoming obstacles from start-up regulations and site selection to patient recruitment and retention. Topics include:

  • The history and current state of gene therapy research
  • The three principal approaches to gene editing
  • GMO regulations and other regulatory considerations

Click here to download our white paper Operationalizing Gene Therapy Trials.

Premier Research. Built for BiotechSM.




Want to reach 137,000+ FierceBiotech subscribers with your own message?
Contact [email protected] or call 202-824-5074.



About this email: In order to receive FierceBiotech for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceBiotech.
Click here to unsubscribe. Refer to our Privacy Policy.

FierceMarkets, a division of Questex, LLC
1900 L St. NW Suite 400 
Washington, DC 20036